Clinical Trial Update: Biology Studies of Hematologic Cancers

View source ↗

Summary

The document reports an NCI-sponsored biology-focused clinical trial update in hematologic cancers, with enrollment by invitation for conditions including acute…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Hodgkin Lymphoma
• Myelodysplastic Syndrome
• Non-hodgkin Lymphoma

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome (MDS) | Status: ENROLLING_BY_INVITATION